Science and Discovery

Lilly

1 article

A scientist in a modern lab examining a glowing molecular model, representing Lilly's new oral obesity drug aleniglipron and its promising safety profile.
Cosmos & Space

Lilly's oral obesity drug shows promising safety and tolerability

Lilly's experimental oral obesity drug, aleniglipron, helped patients lose up to 12.

Aram Sarkisian·June 7, 2026